[
  {
    "date": "2023-12-30",
    "symbol": "GTHX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2023-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38096",
    "entityregistrantname": "G1 THERAPEUTICS, INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "26-3648180",
    "entityaddressaddressline1": "700 Park Offices Drive",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Research Triangle Park",
    "entityaddressstateorprovince": "NC",
    "entityaddresspostalzipcode": 27709,
    "cityareacode": 919,
    "localphonenumber": "213-9835",
    "security12btitle": "Common Stock $.0001 par value",
    "tradingsymbol": "GTHX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "false",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1560241,
    "amendmentflag": "false",
    "documentfiscalperiodfocus": "FY",
    "documentfiscalyearfocus": 2023,
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "New York, NY, United States",
    "cashandcashequivalentsatcarryingvalue": 32218000,
    "restrictedcashcurrent": 63000,
    "marketablesecuritiescurrent": 49938000,
    "accountsreceivablenetcurrent": 12687000,
    "inventorynet": 12442000,
    "prepaidexpenseandotherassetscurrent": 7600000,
    "assetscurrent": 114948000,
    "propertyplantandequipmentnet": 1476000,
    "restrictedcashnoncurrent": 187000,
    "operatingleaserightofuseasset": 4908000,
    "otherassets": 21000,
    "assets": 121540000,
    "accountspayablecurrent": 3992000,
    "accruedliabilitiescurrent": 21893000,
    "deferredrevenuecurrent": 620000,
    "otherliabilitiescurrent": 3211000,
    "liabilitiescurrent": 29716000,
    "loanspayable": 51557000,
    "deferredrevenue": 500000,
    "operatingleaseliabilitynoncurrent": 4340000,
    "otherliabilitiesnoncurrent": 41000,
    "liabilities": 86154000,
    "commonstockvalueoutstanding": 5000,
    "treasurystockcommonvalue": 8000,
    "additionalpaidincapitalcommonstock": 815374000,
    "retainedearningsaccumulateddeficit": -779985000,
    "stockholdersequity": 35386000,
    "liabilitiesandstockholdersequity": 121540000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 46344000,
    "operatingcostsandexpenses": 7195000,
    "researchanddevelopmentexpense": 43711000,
    "sellinggeneralandadministrativeexpense": 71132000,
    "operatingexpenses": 122038000,
    "operatingincomeloss": -39527000,
    "othernonoperatinginterestincome": 2473000,
    "othernonoperatinginterestexpense": 10038000,
    "otherincomeexpense": 2240000,
    "othernonoperatingincomeexpense": -5325000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -44852000,
    "incometaxexpensebenefit": 3115000,
    "netincomeloss": -47967000,
    "earningspersharebasic": -0.93,
    "earningspersharediluted": -0.93,
    "weightedaveragenumberofsharesoutstandingbasic": 51733487,
    "weightedaveragenumberofdilutedsharesoutstanding": 51733487,
    "commonstocksharesoutstanding": 51926075,
    "treasurystockcommonshares": 26666,
    "stockissuedduringperiodvaluenewissues": 39000,
    "stockissuedduringperiodsharesstockoptionsexercised": 165180,
    "stockissuedduringperiodvaluestockoptionsexercised": 57000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 261461,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 14510000,
    "profitloss": -47967000,
    "sharebasedcompensation": 14510000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 2272000,
    "depreciationdepletionandamortization": 513000,
    "amortizationoffinancingcosts": 1473000,
    "noncashinterestexpense": 609000,
    "increasedecreaseinaccountsreceivable": 1593000,
    "increasedecreaseininventories": -3737000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -548000,
    "increasedecreaseinaccountspayable": -3372000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": -4636000,
    "increasedecreaseindeferredrevenue": 113000,
    "netcashprovidedbyusedinoperatingactivities": -38337000,
    "paymentstoacquiremarketablesecurities": 124690000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 127500000,
    "netcashprovidedbyusedininvestingactivities": 2810000,
    "proceedsfromstockoptionsexercised": 57000,
    "repaymentsofdebt": 26688000,
    "paymentsofstockissuancecosts": 281000,
    "netcashprovidedbyusedinfinancingactivities": -26912000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -62439000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 32468000,
    "interestpaidnet": 8807000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 51952741,
    "restrictedcash": 250000,
    "unbilledreceivablescurrent": 200000,
    "debtinstrumentcarryingamount": 51600000,
    "patentrelatedlegalexpenses": 1800000,
    "allocatedsharebasedcompensationexpense": 243000,
    "propertyplantandequipmentusefullife": "P5Y",
    "cashandcashequivalentsfairvaluedisclosure": 32110000,
    "availableforsalesecuritiesdebtsecurities": 49938000,
    "assetsfairvaluedisclosure": 82048000,
    "inventoryrawmaterials": 2422000,
    "inventoryworkinprocess": 9593000,
    "inventoryfinishedgoods": 427000,
    "propertyplantandequipmentgross": 327000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2339000,
    "accruedexternalresearch": 109000,
    "accruedprofessionalfeesandothercurrent": 5854000,
    "accruedexternalclinicalstudycosts": 10944000,
    "employeerelatedliabilitiescurrent": 4986000,
    "lesseeoperatingleaserenewalterm": "P5Y",
    "operatingleaseliabilitycurrent": 1276000,
    "cashpaymentsformeasurementofoperatingleases": 1600000,
    "leaserightofuseasset": 4908000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#OtherLiabilitiesCurrent",
    "operatingleaseliability": 5616000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y9M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleasecost": 630000,
    "leasecost": 1554000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1679000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1725000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1773000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1357000,
    "lesseeoperatingleaseliabilitypaymentsdue": 6534000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 918000,
    "debtinstrumentbasisspreadonvariablerate1": 0.064,
    "debtinstrumentinterestratestatedpercentage": 0.0965,
    "percentageofprepaymentloanamountforyearfirst": 0.03,
    "percentageofprepaymentloanamountforyearsecond": 0.02,
    "percentageofprepaymentloanamountforyearthird": 0.01,
    "debtinstrumentpercentageofallloanadvancesamountfee": 0.0695,
    "debtinstrumentendoftermfeeamount": 2100000,
    "debtinstrumentcovenantoutstandingdebtthreshold": 50000000,
    "debtinstrumentinterestrateeffectivepercentage": 0.1833,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 1819000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 23469000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 24712000,
    "longtermdebt": 50000000,
    "debtinstrumentperiodicpayment": 2011000,
    "unamortizeddebtissuanceexpense": 454000,
    "commonstocknumberofvotespershare": 1,
    "preferredstocksharesauthorized": 5000000,
    "commonstockcapitalsharesreservedforfutureissuance": 6774186,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1473163,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 9700000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P1Y10M24D",
    "numberofcommonsharesreceiveduponvesting": 1,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 5400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.814,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.884,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.034,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.47,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6774186,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1369330,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1801992,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4813088,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 6774186,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 13.6,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 4.79,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 18.56,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 15.8,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 13.6,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y4M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 944000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 859000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 944000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 1613215,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 1617050,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 417780,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 261461,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 5.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 3.76,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 6.41,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 12.38,
    "upfrontcashpaymentreceived": 30000000,
    "percentageofequityinterest": 0.065,
    "revenuerecognizedforreimbursementofclinicaltrialscosts": 1700000,
    "contractwithcustomerliabilitycurrent": 200000,
    "revenuerecognizedforreimbursementofsupplymanufacturingservicesandpatentcosts": 2900000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7507583,
    "deferredtaxassetsinprocessresearchanddevelopment": 21546000,
    "valuationallowancedeferredtaxassetchangeinamount": -9900000,
    "deferredtaxassetsvaluationallowance": 183740000,
    "operatinglosscarryforwards": 550700000,
    "operatinglosscarryforwardssubjecttoexpiration": 93500000,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 457200000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 23351000,
    "currentforeigntaxexpensebenefit": 3115000,
    "currentincometaxexpensebenefit": 3115000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -9419000,
    "incometaxreconciliationstateandlocalincometaxes": -706000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 9868000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 3873000,
    "incometaxreconciliationtaxcreditsresearch": 2835000,
    "incometaxreconciliationforeignincometaxratedifferential": 3115000,
    "incometaxreconciliationdeductionsextraterritorialincomeexclusion": 654000,
    "incometaxreconciliationotherreconcilingitems": -127000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2966000,
    "deferredtaxassetsoperatingleaseliabilities": 1337000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 9223000,
    "deferredtaxassetsoperatinglosscarryforwards": 120626000,
    "deferredtaxassetsnondeductibleinterest": 3691000,
    "deferredtaxassetsother": 2160000,
    "deferredtaxassetsgross": 184900000,
    "deferredtaxliabilitiesleasingarrangements": 1160000,
    "deferredincometaxliabilities": 1160000,
    "valuationallowancesandreservesbalance": 183740000,
    "valuationallowancesandreserveschargedtocostandexpense": 9868000,
    "salarieswagesandofficerscompensation": 50000
  },
  {
    "date": "2022-12-30",
    "symbol": "GTHX",
    "period": "FY",
    "documenttype": "10-K",
    "documentannualreport": "true",
    "documentperiodenddate": "2022-12-31",
    "currentfiscalyearenddate": "--12-31",
    "documenttransitionreport": "false",
    "entityfilenumber": "001-38096",
    "entityregistrantname": "G1 THERAPEUTICS, INC.",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "26-3648180",
    "entityaddressaddressline1": "700 Park Offices Drive",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Research Triangle Park",
    "entityaddressstateorprovince": "NC",
    "entityaddresspostalzipcode": 27709,
    "cityareacode": 919,
    "localphonenumber": "213-9835",
    "security12btitle": "Common Stock $.0001 par value",
    "tradingsymbol": "GTHX",
    "securityexchangename": "NASDAQ",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Non-accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitycentralindexkey": 1560241,
    "amendmentflag": "false",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "New York, NY, United States",
    "cashandcashequivalentsatcarryingvalue": 94594000,
    "restrictedcashcurrent": 63000,
    "marketablesecuritiescurrent": 50476000,
    "accountsreceivablenetcurrent": 11094000,
    "inventorynet": 16179000,
    "prepaidexpenseandotherassetscurrent": 7094000,
    "assetscurrent": 179500000,
    "propertyplantandequipmentnet": 1989000,
    "restrictedcashnoncurrent": 250000,
    "operatingleaserightofuseasset": 5962000,
    "otherassets": 264000,
    "assets": 187965000,
    "accountspayablecurrent": 7431000,
    "accruedliabilitiescurrent": 25557000,
    "deferredrevenuecurrent": 7000,
    "otherliabilitiescurrent": 2593000,
    "liabilitiescurrent": 35588000,
    "loanspayable": 77015000,
    "deferredrevenue": 1000000,
    "operatingleaseliabilitynoncurrent": 5615000,
    "liabilities": 119218000,
    "commonstockvalue": 5000,
    "treasurystockcommonvalue": 8000,
    "additionalpaidincapitalcommonstock": 800768000,
    "retainedearningsaccumulateddeficit": -732018000,
    "stockholdersequity": 68747000,
    "liabilitiesandstockholdersequity": 187965000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 31337000,
    "operatingcostsandexpenses": 3748000,
    "researchanddevelopmentexpense": 83316000,
    "sellinggeneralandadministrativeexpense": 100415000,
    "operatingexpenses": 187479000,
    "operatingincomeloss": -136178000,
    "othernonoperatinginterestincome": 748000,
    "othernonoperatinginterestexpense": 10432000,
    "otherincomeexpense": 3000,
    "othernonoperatingincomeexpense": -9681000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -145859000,
    "incometaxexpensebenefit": 1700000,
    "netincomeloss": -147559000,
    "earningspersharebasic": -3.38,
    "earningspersharediluted": -3.38,
    "weightedaveragenumberofsharesoutstandingbasic": 43626113,
    "weightedaveragenumberofdilutedsharesoutstanding": 43626113,
    "commonstocksharesoutstanding": 51499434,
    "treasurystockcommonshares": 26666,
    "stockissuedduringperiodsharesnewissues": 8573353,
    "stockissuedduringperiodvaluenewissues": 1000,
    "stockissuedduringperiodsharesstockoptionsexercised": 206608,
    "stockissuedduringperiodvaluestockoptionsexercised": 155000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 157325,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationstockoptionsrequisiteserviceperiodrecognition": 20589000,
    "profitloss": -147559000,
    "sharebasedcompensation": 20589000,
    "accretionamortizationofdiscountsandpremiumsinvestments": 453000,
    "depreciationdepletionandamortization": 530000,
    "amortizationoffinancingcosts": 2233000,
    "noncashinterestexpense": 850000,
    "noncashequityinterestnet": 497000,
    "increasedecreaseinaccountsreceivable": 5406000,
    "increasedecreaseininventories": 12708000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -7184000,
    "increasedecreaseinaccountspayable": 4421000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 1226000,
    "increasedecreaseindeferredrevenue": -24000,
    "netcashprovidedbyusedinoperatingactivities": -128620000,
    "paymentstoacquiremarketablesecurities": 65023000,
    "proceedsfromsaleandmaturityofmarketablesecurities": 15000000,
    "paymentstoacquirepropertyplantandequipment": 506000,
    "netcashprovidedbyusedininvestingactivities": -50529000,
    "proceedsfromstockoptionsexercised": 155000,
    "proceedsfromissuanceinitialpublicoffering": 52383000,
    "paymentsofstockissuancecosts": 43000,
    "netcashprovidedbyusedinfinancingactivities": 52495000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -126654000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 94907000,
    "interestpaidnet": 7924000,
    "upfrontprojectcostsandothercurrentassetsinaccountspayableandaccruedexpenses": 47000,
    "publicofferingcostsinaccountspayableandaccruedexpenses": 320000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 51526100,
    "upfrontcashpaymentreceived": 14000000,
    "milestonepaymentsnumberofpaymentsreceived": 2,
    "propertyplantandequipmentusefullife": "P5Y",
    "cashandcashequivalentsfairvaluedisclosure": 84167000,
    "availableforsalesecuritiesdebtsecurities": 50476000,
    "assetsfairvaluedisclosure": 134643000,
    "restrictedcash": 300000,
    "unbilledreceivablescurrent": 2300000,
    "patentrelatedlegalexpenses": 1800000,
    "inventoryrawmaterials": 2790000,
    "inventoryworkinprocess": 10153000,
    "inventoryfinishedgoods": 3236000,
    "propertyplantandequipmentgross": 327000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1826000,
    "depreciation": 530000,
    "accruedexternalresearch": 268000,
    "accruedprofessionalfeesandothercurrent": 4304000,
    "accruedexternalclinicalstudycosts": 15566000,
    "employeerelatedliabilitiescurrent": 5419000,
    "lesseeoperatingleaserenewalterm": "P5Y",
    "operatingleaseliabilitycurrent": 1135000,
    "cashpaymentsformeasurementofoperatingleases": 1703000,
    "leaserightofuseasset": 5962000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#OtherLiabilitiesCurrent",
    "operatingleaseliability": 6750000,
    "operatingleaseweightedaverageremainingleaseterm1": "P4Y9M18D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleasecost": 618000,
    "leasecost": 1666000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1634000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1679000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1725000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1773000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1357000,
    "lesseeoperatingleaseliabilitypaymentsdue": 8168000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1418000,
    "debtinstrumentcurrentborrowingcapacitywithoutfinancialcovenants": 40000000,
    "debtinstrumentbasisspreadonvariablerate1": 0.064,
    "debtinstrumentinterestratestatedpercentage": 0.0965,
    "percentageofprepaymentloanamountforyearfirst": 0.03,
    "percentageofprepaymentloanamountforyearsecond": 0.02,
    "percentageofprepaymentloanamountforyearthird": 0.01,
    "debtinstrumentpercentageofallloanadvancesamountfee": 0.0695,
    "debtinstrumentendoftermfeeamount": 2100000,
    "debtinstrumentminimumrevenueofcovenantmarketcapitalizationamount": 750000000,
    "debtinstrumentpercentageofminimumrevenueofcovenantunrestrictedcash": 0.5,
    "debtinstrumentpercentageofunrestrictedcash": 1,
    "debtinstrumentpercentageofnetproductrevenue": 0.65,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 2742000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 35287000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 36971000,
    "longtermdebt": 75000000,
    "debtinstrumentperiodicpayment": 2709000,
    "unamortizeddebtissuanceexpense": 695000,
    "debtinstrumentcarryingamount": 77014000,
    "commonstocknumberofvotespershare": 1,
    "preferredstocksharesauthorized": 5000000,
    "commonstockcapitalsharesreservedforfutureissuance": 7372028,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1738639,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 22400000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y2M12D",
    "numberofcommonsharesreceiveduponvesting": 1,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 5800000,
    "allocatedsharebasedcompensationexpense": 207000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.767,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.814,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.014,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.042,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.5,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7372028,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 1759539,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 882630,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 4562674,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 7372028,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 16.15,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 9.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 19.87,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 0.75,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 17.85,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 16.15,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y9M18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P6Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 3281000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 3248000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 3281000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 675406,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 510831,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 93091,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiod": 157325,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 12.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 9.43,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 12.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedinperiodweightedaveragegrantdatefairvalue": 18.58,
    "revenueremainingperformanceobligationnumber": 1,
    "revenuerecognizedforreimbursementofclinicaltrialscosts": 2400000,
    "revenuerecognizedforreimbursementofpatentcosts": 300000,
    "revenuerecognizedforreimbursementoflicenserevenuesupply": 700000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7692064,
    "currentforeigntaxexpensebenefit": 1700000,
    "currentincometaxexpensebenefit": 1700000,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -30631000,
    "incometaxreconciliationstateandlocalincometaxes": -5372000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 36472000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 2879000,
    "incometaxreconciliationtaxcreditsresearch": 3521000,
    "incometaxreconciliationforeignincometaxratedifferential": 1700000,
    "incometaxreconciliationotherreconcilingitems": 173000,
    "deferredtaxassetsinprocessresearchanddevelopment": 17945000,
    "valuationallowancedeferredtaxassetchangeinamount": 36500000,
    "deferredtaxassetsvaluationallowance": 173872000,
    "operatinglosscarryforwards": 545100000,
    "operatinglosscarryforwardssubjecttoexpiration": 95400000,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 449700000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 20516000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 4127000,
    "deferredtaxassetsoperatingleaseliabilities": 1596000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 10518000,
    "deferredtaxassetsoperatinglosscarryforwards": 117896000,
    "deferredtaxassetsnondeductibleinterest": 2178000,
    "deferredtaxassetsother": 571000,
    "deferredtaxassetsgross": 175347000,
    "deferredtaxliabilitiesleasingarrangements": 1410000,
    "deferredtaxliabilitiesother": 65000,
    "deferredincometaxliabilities": 1475000,
    "valuationallowancesandreservesbalance": 173872000,
    "valuationallowancesandreserveschargedtocostandexpense": 36472000
  },
  {
    "date": "2021-12-30",
    "symbol": "GTHX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2021-12-31",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "GTHX",
    "entityregistrantname": "G1 THERAPEUTICS, INC.",
    "entitycentralindexkey": 1560241,
    "currentfiscalyearenddate": "--12-31",
    "security12btitle": "Common Stock $.0001 par value",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "entitywellknownseasonedissuer": "No",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "icfrauditorattestationflag": "true",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38096",
    "entityaddressaddressline1": "700 Park Offices Drive",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Research Triangle Park",
    "entityaddressstateorprovince": "NC",
    "entityaddresspostalzipcode": 27709,
    "cityareacode": 919,
    "localphonenumber": "213-9835",
    "entitytaxidentificationnumber": "26-3648180",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "auditorfirmid": 238,
    "auditorname": "PricewaterhouseCoopers LLP",
    "auditorlocation": "New York, NY, United States",
    "cashandcashequivalentsatcarryingvalue": 221186000,
    "restrictedcashcurrent": 63000,
    "accountsreceivablenetcurrent": 5688000,
    "inventorynet": 3471000,
    "prepaidexpenseandotherassetscurrent": 13157000,
    "assetscurrent": 243565000,
    "propertyplantandequipmentnet": 2013000,
    "restrictedcashnoncurrent": 312000,
    "operatingleaserightofuseasset": 7035000,
    "otherassets": 1169000,
    "assets": 254094000,
    "accountspayablecurrent": 2897000,
    "accruedliabilitiescurrent": 23180000,
    "deferredrevenuecurrent": 31000,
    "otherliabilitiescurrent": 1505000,
    "liabilitiescurrent": 27613000,
    "loanspayable": 75190000,
    "deferredrevenue": 1000000,
    "operatingleaseliabilitynoncurrent": 6750000,
    "liabilities": 110553000,
    "commonstockvalue": 4000,
    "treasurystockvalue": 8000,
    "additionalpaidincapitalcommonstock": 728004000,
    "retainedearningsaccumulateddeficit": -584459000,
    "stockholdersequity": 143541000,
    "liabilitiesandstockholdersequity": 254094000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 42588814,
    "commonstocksharesoutstanding": 42562148,
    "treasurystockshares": 26666,
    "revenuefromcontractwithcustomerexcludingassessedtax": 11120000,
    "operatingcostsandexpenses": 2016000,
    "researchanddevelopmentexpense": 76225000,
    "sellinggeneralandadministrativeexpense": 95692000,
    "operatingexpenses": 173933000,
    "operatingincomeloss": -142457000,
    "othernonoperatinginterestincome": 43000,
    "othernonoperatinginterestexpense": 4667000,
    "otherincomeexpense": -346000,
    "othernonoperatingincomeexpense": -4970000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -147427000,
    "incometaxexpensebenefit": 925000,
    "netincomeloss": -148352000,
    "earningspersharebasicanddiluted": -3.54,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 41943417,
    "sharesoutstanding": 42588814,
    "atthemarketpublicofferingvalueofsharesissued": 86378000,
    "atthemarketpublicofferingsharesissued": 3513027,
    "stockissuedduringperiodvaluestockoptionsexercised": 5845000,
    "stockissuedduringperiodsharesstockoptionsexercised": 935031,
    "adjustmenttoadditionalpaidincapitalincometaxeffectfromsharebasedcompensationnet": 22319000,
    "profitloss": -148352000,
    "sharebasedcompensation": 22319000,
    "depreciationdepletionandamortization": 469000,
    "amortizationoffinancingcosts": 1113000,
    "gainslossesonextinguishmentofdebt": -220000,
    "noncashinterestexpense": 591000,
    "noncashequityinterestnet": 370000,
    "increasedecreaseinaccountsreceivable": 5451000,
    "increasedecreaseininventories": 3471000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3380000,
    "increasedecreaseinaccountspayable": -675000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 3345000,
    "increasedecreaseindeferredrevenue": 794000,
    "netcashprovidedbyusedinoperatingactivities": -132108000,
    "proceedsfromstockoptionsandwarrantsexercised": 5845000,
    "proceedsfromloanagreement": 55000000,
    "paymentsofdebtissuancecosts": 1360000,
    "proceedsfromissuanceinitialpublicoffering": 86429000,
    "paymentsofstockissuancecosts": 51000,
    "netcashprovidedbyusedinfinancingactivities": 145863000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 13755000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 221561000,
    "interestpaidnet": 2908000,
    "entitynumberofemployees": 34,
    "eligibletoreceivemaximumdevelopmentandcommercialmilestonepayments": 156000000,
    "receiveddevelopmentandcommercialmilestonepayments": 8000000,
    "upfrontpaymentsreceivableandsalesbasedroyalties": 26000000,
    "maximummilestonepayments": 330000000,
    "expectedperiodtofundoperationsbyexistingcashresources": "P12M",
    "securitydeposit": 500000,
    "restrictedcash": 400000,
    "legalfees": 1934000,
    "propertyplantandequipmentestimatedusefullives": "5 years",
    "assetsfairvaluedisclosure": 110443000,
    "inventoryrawmaterials": 2105000,
    "inventoryworkinprocess": 1342000,
    "inventoryfinishedgoods": 24000,
    "propertyplantandequipmentgross": 327000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 1296000,
    "depreciation": 469000,
    "licenseagreementdate": "2016-11-23",
    "licenseagreementamendmentdate": "2017-03-24",
    "milestonepayments": 2600000,
    "licenseagreementterminationnoticeperiod": "P90D",
    "accruedexternalresearch": 773000,
    "accruedprofessionalfeesandothercurrent": 8058000,
    "accruedexternalclinicalstudycosts": 9579000,
    "employeerelatedliabilitiescurrent": 4770000,
    "cashpaymentsformeasurementofoperatingleases": 1668000,
    "leaserightofuseasset": 7035000,
    "operatingleaseliabilitycurrent": 1115000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent",
    "operatingleaseliability": 7865000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y8M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleasecost": 799000,
    "leasecost": 1669000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1703000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1634000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1679000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1725000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1773000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 1357000,
    "lesseeoperatingleaseliabilitypaymentsdue": 9871000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2006000,
    "debtinstrumentunusedborrowingcapacityamount": 10000000,
    "debtinstrumentcurrentborrowingcapacitywithoutfinancialcovenants": 40000000,
    "debtinstrumentmaturitydaterangestart1": "2022-06-01",
    "debtinstrumentmaturitydaterangeend1": "2023-01-01",
    "debtinstrumentmaturitydate": "2025-06-01",
    "debtinstrumentmaturitydatedescription": "following the interest only period, the Company will repay the principal balance and interest of the advances in equal monthly installments through June 1, 2024.",
    "debtinstrumentinterestrateterms": "greater of either (i) (a) the prime rate as reported in The Wall Street Journal, plus (b) 6.40%, and (ii) 9.65%.",
    "debtinstrumentbasisspreadonvariablerate1": 0.064,
    "debtinstrumentinterestratestatedpercentage": 0.0965,
    "prepaymentfeedescription": "3.0% of the prepayment amount in the first year; (b) 2.0% of the prepayment amount in the second year; and (c) 1.0% of the prepayment amount in the third year",
    "percentageofprepaymentloanamountforyearfirst": 0.03,
    "percentageofprepaymentloanamountforyearsecond": 0.02,
    "percentageofprepaymentloanamountforyearthird": 0.01,
    "debtinstrumentendoftermfeeamount": 2100000,
    "debtinstrumentpercentageofallloanadvancesamountfee": 0.0695,
    "debtinstrumentpercentageofloanamountprepaymentcharge": 0.0695,
    "debtinstrumentpercentageofnetproductrevenue": 0.65,
    "debtinstrumentminimumrevenueofcovenantmarketcapitalizationamount": 750000000,
    "debtinstrumentpercentageofminimumrevenueofcovenantunrestrictedcash": 0.5,
    "debtinstrumentpercentageofunrestrictedcash": 1,
    "extinguishmentofdebtamount": 200000,
    "extinguishmentofdebtnatureofrestrictionsonassetssetasideforscheduledpayments": "Agreement as of November 1, 2021, including the unamortized debt issuance costs, and the fair value of the Second Amendment was recorded as a $0.2 million loss on extinguishment of debt for the twelve months ended December 31, 2021",
    "interestexpensedebt": 4700000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 2860000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 35993000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfive": 36147000,
    "longtermdebt": 75000000,
    "debtinstrumentperiodicpayment": 1124000,
    "unamortizeddebtissuanceexpense": 934000,
    "debtinstrumentcarryingamount": 75190000,
    "commonstockvotingrights": "Holders of common stock are entitled to one vote per share",
    "preferredstocksharesauthorized": 5000000,
    "commonstockcapitalsharesreservedforfutureissuance": 6701727,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesauthorized": 500000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 1307735,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 33500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y4M24D",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 5200000,
    "allocatedsharebasedcompensationexpense": 252000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.768,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.796,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.004,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.013,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 11.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6701727,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2168053,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 1176075,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3660578,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 6701727,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 17.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 17.77,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 21.4,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 16.72,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 17.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P5Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 10427000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 10422000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 10427000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestednumber": 414991,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiod": 507906,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeitedinperiod": 92915,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsnonvestedweightedaveragegrantdatefairvalue": 18.24,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 18.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsforfeituresweightedaveragegrantdatefairvalue": 18.07,
    "upfrontcashpaymentreceived": 14000000,
    "revenuefromcontractwithcustomerincludingassessedtax": 3000000,
    "manufacturingcosts": 2500000,
    "withholdingtaxes": 800000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 7056745,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxassetsvaluationallowance": 137400000,
    "increaseindeferredtaxassetsvaluationallowance": 27600000,
    "operatinglosscarryforwards": 510000000,
    "operatinglosscarryforwardsexpirationyear": 2029,
    "operatinglosscarryforwardssubjecttoexpiration": 95400000,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 414600000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 16995000,
    "taxcreditcarryforwardexpirationyear": 2035,
    "currentforeigntaxexpensebenefit": 925,
    "currentincometaxexpensebenefit": 925,
    "deferredincometaxexpensebenefit": 925,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -30960000,
    "incometaxreconciliationstateandlocalincometaxes": 1923000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 27618000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 108000,
    "incometaxreconciliationtaxcreditsresearch": 3030000,
    "incometaxreconciliationchangeinenactedtaxrate": 8359000,
    "incometaxreconciliationtaxcreditsforeign": 925000,
    "incometaxreconciliationotherreconcilingitems": 172000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2633000,
    "deferredtaxassetsoperatingleaseliabilities": 1730000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 9037000,
    "deferredtaxassetsoperatinglosscarryforwards": 108489000,
    "deferredtaxassetsother": 191000,
    "deferredtaxassetsgross": 139075000,
    "deferredtaxliabilitiesleasingarrangements": 1548000,
    "deferredtaxliabilitiesother": 127000,
    "deferredincometaxliabilities": 1675000,
    "valuationallowancesandreservesbalance": 137400000,
    "valuationallowancesandreserveschargedtocostandexpense": 35961000,
    "valuationallowancesandreservesdeductions": 8343000,
    "relatedpartytransactionamountsoftransaction": 3000,
    "consultingagreementsexpirationdate": "2021-06-30",
    "salarieswagesandofficerscompensation": 50000,
    "accruedemployeebenefitscurrent": 25000,
    "relatedpartytransactiondate": "2023-12-31"
  },
  {
    "date": "2020-12-30",
    "symbol": "GTHX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "GTHX",
    "entityregistrantname": "G1 THERAPEUTICS, INC.",
    "entitycentralindexkey": 1560241,
    "currentfiscalyearenddate": "--12-31",
    "security12btitle": "Common Stock $.0001 par value",
    "securityexchangename": "NASDAQ",
    "entityincorporationstatecountrycode": "DE",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "icfrauditorattestationflag": "true",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38096",
    "entityaddressaddressline1": "700 Park Offices Drive",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Research Triangle Park",
    "entityaddressstateorprovince": "NC",
    "entityaddresspostalzipcode": 27709,
    "cityareacode": 919,
    "localphonenumber": "213-9835",
    "entitytaxidentificationnumber": "26-3648180",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 207306000,
    "restrictedcashcurrent": 63000,
    "accountsreceivablenetcurrent": 237000,
    "prepaidexpenseandotherassetscurrent": 8786000,
    "assetscurrent": 216392000,
    "propertyplantandequipmentnet": 2482000,
    "restrictedcash": 437000,
    "operatingleaserightofuseasset": 8026000,
    "otherassets": 1215000,
    "assets": 228552000,
    "accountspayablecurrent": 3572000,
    "accruedliabilitiescurrent": 16486000,
    "deferredrevenuecurrent": 237000,
    "otherliabilitiescurrent": 3148000,
    "liabilitiescurrent": 23443000,
    "loanspayable": 19893000,
    "operatingleaseliabilitynoncurrent": 7865000,
    "liabilities": 51201000,
    "commonstockvalue": 4000,
    "treasurystockvalue": 8000,
    "additionalpaidincapitalcommonstock": 613462000,
    "retainedearningsaccumulateddeficit": -436107000,
    "stockholdersequity": 177351000,
    "liabilitiesandstockholdersequity": 228552000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": 120000000,
    "commonstocksharesissued": 38140756,
    "commonstocksharesoutstanding": 38114090,
    "treasurystockshares": 26666,
    "revenuefromcontractwithcustomerincludingassessedtax": 45285000,
    "typeofrevenueextensiblelist": "us-gaap:LicenseMember",
    "researchanddevelopmentexpense": 73271000,
    "generalandadministrativeexpense": 68490000,
    "operatingexpenses": 141761000,
    "operatingincomeloss": -96476000,
    "othernonoperatinginterestincome": 952000,
    "othernonoperatinginterestexpense": 1778000,
    "otherincomeexpense": -542000,
    "othernonoperatingincomeexpense": -1368000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -97844000,
    "incometaxexpensebenefit": 1410000,
    "netincomeloss": -99254000,
    "earningspersharebasicanddiluted": -2.62,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 37878026,
    "sharesoutstanding": 38140756,
    "stockissuedduringperiodvaluestockoptionsexercised": 2308000,
    "stockissuedduringperiodsharesstockoptionsexercised": 502496,
    "adjustmenttoadditionalpaidincapitalincometaxeffectfromsharebasedcompensationnet": 18770000,
    "profitloss": -99254000,
    "sharebasedcompensation": 18770000,
    "depreciationdepletionandamortization": 582000,
    "gainlossonsaleofpropertyplantequipment": -322000,
    "amortizationoffinancingcosts": 615000,
    "noncashinterestexpense": 166000,
    "noncashequityinterestnet": -867000,
    "increasedecreaseinaccountsreceivable": 237000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 5545000,
    "increasedecreaseinaccountspayable": -244000,
    "increasedecreaseinaccruedliabilitiesandotheroperatingliabilities": 1713000,
    "increasedecreaseindeferredrevenue": 237000,
    "netcashprovidedbyusedinoperatingactivities": -83742000,
    "proceedsfromsaleofpropertyplantandequipment": 152000,
    "netcashprovidedbyusedininvestingactivities": 152000,
    "proceedsfromstockoptionsandwarrantsexercised": 2308000,
    "proceedsfromloanagreement": 20000000,
    "paymentsofdebtissuancecosts": 620000,
    "netcashprovidedbyusedinfinancingactivities": 21688000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -61902000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 207806000,
    "interestpaidnet": 997000,
    "upfrontprojectcostsandothercurrentassetsinaccountspayableandaccruedexpenses": 132000,
    "numberofclinicalstageproductcandidatesfrompipeline": 2,
    "maximummilestonepayments": 156000000,
    "upfrontpaymentsreceivableandsalesbasedroyalties": 14000000,
    "expectedperiodtofundoperationsbyexistingcashresources": "P12M",
    "securitydeposit": 500000,
    "legalfees": 2761000,
    "propertyplantandequipmentestimatedusefullives": "5 years",
    "assetsfairvaluedisclosure": 190180000,
    "propertyplantandequipmentgross": 327000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 827000,
    "depreciation": 582000,
    "licenseagreementdate": "2016-11-23",
    "licenseagreementamendmentdate": "2017-03-24",
    "milestonepayments": 2600000,
    "licenseagreementterminationnoticeperiod": "P90D",
    "accruedexternalresearch": 3219000,
    "accruedprofessionalfeesandothercurrent": 3920000,
    "accruedexternalclinicalstudycosts": 5683000,
    "employeerelatedliabilitiescurrent": 3664000,
    "cashpaymentsformeasurementofoperatingleases": 1683000,
    "leaserightofuseasset": 8026000,
    "operatingleaseliabilitycurrent": 988000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherLiabilitiesCurrent",
    "operatingleaseliability": 8853000,
    "operatingleaseweightedaverageremainingleaseterm1": "P6Y7M6D",
    "operatingleaseweightedaveragediscountratepercent": 0.08,
    "operatingleasecost": 955000,
    "leasecost": 2146000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1657000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1703000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1634000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1679000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1725000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 3131000,
    "lesseeoperatingleaseliabilitypaymentsdue": 11529000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 2676000,
    "debtinstrumentfaceamount": 100000000,
    "debtinstrumentcarryingamount": 19893000,
    "debtinstrumentmaturitydaterangestart1": "2022-06-01",
    "debtinstrumentmaturitydaterangeend1": "2023-01-01",
    "debtinstrumentmaturitydatedescription": "Following the interest only period, the Company will repay the principal balance and interest of the advances in equal monthly installments through June 1, 2024.",
    "debtinstrumentinterestrateterms": "greater of either (i) (a) the prime rate as reported in The Wall Street Journal, plus (b) 6.40%, and (ii) 9.65%.",
    "debtinstrumentbasisspreadonvariablerate1": 0.064,
    "debtinstrumentinterestratestatedpercentage": 0.0965,
    "prepaymentfeedescription": "3.0% of the prepayment amount in the first year; (b) 2.0% of the prepayment amount in the second year; and (c) 1.0% of the prepayment amount in the third year",
    "percentageofprepaymentloanamountforyearfirst": 0.03,
    "percentageofprepaymentloanamountforyearsecond": 0.02,
    "percentageofprepaymentloanamountforyearthird": 0.01,
    "debtinstrumentendoftermfeeamount": 2100000,
    "debtinstrumentpercentageofallloanadvancesamountfee": 0.0695,
    "debtinstrumentpercentageofloanamountprepaymentcharge": 0.0695,
    "deferredfinancecostsnet": 400000,
    "lineofcreditfacilityupfrontfee": 200000,
    "longtermdebt": 19400000,
    "interestexpensedebt": 1800000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 4631000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 9972000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 5397000,
    "debtinstrumentperiodicpayment": 395000,
    "unamortizeddebtissuanceexpense": 502000,
    "commonstockvotingrights": "Holders of common stock are entitled to one vote per share",
    "preferredstocksharesauthorized": 5000000,
    "commonstockcapitalsharesreservedforfutureissuance": 6644780,
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 932051,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 38834000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y5M1D",
    "allocatedsharebasedcompensationexpense": 6902000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.748,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.81,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.003,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.017,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 12.17,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 6644780,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 635797,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2039037,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3542190,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": 6644780,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 16.91,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 30.94,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 18.32,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 4.59,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 12.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 16.91,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y3M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y3M19D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 35464000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 31686000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 35464000,
    "upfrontcashpaymentreceived": 200000,
    "revenues": 1300000,
    "contractwithcustomerliabilityrevenuerecognized": 1100000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 6576688,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxassetsvaluationallowance": 109782000,
    "operatinglosscarryforwards": 373100000,
    "operatinglosscarryforwardsexpirationyear": 2029,
    "operatinglosscarryforwardssubjecttoexpiration": 95400000,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 277600000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 13965000,
    "taxcreditcarryforwardexpirationyear": 2035,
    "currentforeigntaxexpensebenefit": 1410,
    "currentincometaxexpensebenefit": 1410,
    "deferredincometaxexpensebenefit": 1410,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -20547000,
    "incometaxreconciliationstateandlocalincometaxes": 1779000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 23782000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 1341000,
    "incometaxreconciliationtaxcreditsresearch": 3091000,
    "incometaxreconciliationtaxcreditsforeign": 1410000,
    "incometaxreconciliationotherreconcilingitems": -294000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2863000,
    "deferredtaxassetsoperatingleaseliabilities": 2034000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7147000,
    "deferredtaxassetsoperatinglosscarryforwards": 85842000,
    "deferredtaxassetsother": 20000,
    "deferredtaxassetsgross": 111871000,
    "deferredtaxliabilitiesleasingarrangements": 1844000,
    "deferredtaxliabilitiesother": 245000,
    "deferredincometaxliabilities": 2089000,
    "valuationallowancesandreservesbalance": 109782000,
    "valuationallowancesandreserveschargedtocostandexpense": 25170000,
    "valuationallowancesandreservesdeductions": 1388000,
    "relatedpartytransactionamountsoftransaction": 6000,
    "senioradvisoragreementexpirationdate": "2023-12-31",
    "salarieswagesandofficerscompensation": 60000
  },
  {
    "date": "2019-12-30",
    "symbol": "GTHX",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2019",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "GTHX",
    "entityregistrantname": "G1 THERAPEUTICS, INC.",
    "entitycentralindexkey": 1560241,
    "currentfiscalyearenddate": "--12-31",
    "security12btitle": "Common Stock $.0001 par value",
    "securityexchangename": "The Nasdaq Stock Market",
    "entityincorporationstatecountrycode": "Delaware",
    "entitywellknownseasonedissuer": "Yes",
    "entitycurrentreportingstatus": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entityfilenumber": "001-38096",
    "entityaddressaddressline1": "700 Park Offices Drive",
    "entityaddressaddressline2": "Suite 200",
    "entityaddresscityortown": "Research Triangle Park",
    "entityaddressstateorprovince": "NC",
    "entityaddresspostalzipcode": 27709,
    "cityareacode": 919,
    "localphonenumber": "213-9835",
    "entitytaxidentificationnumber": "26-3648180",
    "documentannualreport": "true",
    "documenttransitionreport": "false",
    "cashandcashequivalentsatcarryingvalue": 269208000,
    "restrictedcashcurrent": 63000,
    "prepaidexpenseandotherassetscurrent": 1732000,
    "assetscurrent": 271003000,
    "propertyplantandequipmentnet": 3538000,
    "restrictedcash": 437000,
    "operatingleaserightofuseasset": 9853000,
    "assets": 284831000,
    "accountspayablecurrent": 3684000,
    "accruedliabilitiescurrent": 15403000,
    "otherliabilitiescurrent": 682000,
    "liabilitiescurrent": 19769000,
    "operatingleaseliabilitynoncurrent": 9535000,
    "liabilities": 29304000,
    "commonstockvalue": 4000,
    "treasurystockvalue": 8000,
    "additionalpaidincapitalcommonstock": 592384000,
    "retainedearningsaccumulateddeficit": -336853000,
    "stockholdersequity": -336853000,
    "liabilitiesandstockholdersequity": 284831000,
    "commonstockparorstatedvaluepershare": 0.0001,
    "commonstocksharesauthorized": "null",
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": "null",
    "treasurystockshares": 26666,
    "revenuefromcontractwithcustomerproductandserviceextensiblelist": "us-gaap:GrantMember",
    "researchanddevelopmentexpense": 89002000,
    "generalandadministrativeexpense": 40039000,
    "operatingexpenses": 129041000,
    "operatingincomeloss": -129041000,
    "othernonoperatingincome": 6594000,
    "othernonoperatingincomeexpense": 6594000,
    "netincomeloss": -122447000,
    "netincomelossavailabletocommonstockholdersbasic": -122447000,
    "earningspersharebasicanddiluted": -3.27,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": "null",
    "sharesoutstanding": -26666,
    "stockissuedduringperiodvaluestockoptionsexercised": 2705000,
    "stockissuedduringperiodsharesstockoptionsexercised": 369468,
    "adjustmenttoadditionalpaidincapitalincometaxeffectfromsharebasedcompensationnet": 16449000,
    "profitloss": -122447000,
    "depreciationdepletionandamortization": 356000,
    "sharebasedcompensation": 98000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 219000,
    "increasedecreaseinaccountspayable": 248000,
    "increasedecreaseinaccruedliabilities": 6042000,
    "netcashprovidedbyusedinoperatingactivities": -99571000,
    "paymentstoacquirepropertyplantandequipment": 2716000,
    "netcashprovidedbyusedininvestingactivities": -2716000,
    "proceedsfromstockoptionsandwarrantsexercised": 2705000,
    "netcashprovidedbyusedinfinancingactivities": 2705000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -99582000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsincludingdisposalgroupanddiscontinuedoperations": 269708000,
    "upfrontprojectcostsandothercurrentassetsinaccountspayableandaccruedexpenses": 43000,
    "capitalexpendituresincurredbutnotyetpaid": 41000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 8947000,
    "numberofclinicalstageproductcandidatesfrompipeline": 3,
    "expectedperiodtofundoperationsbyexistingcashresources": 12,
    "securitydeposit": 500000,
    "legalfees": 2114000,
    "propertyplantandequipmentestimatedusefullives": "7 years",
    "assetsfairvaluedisclosure": 268436000,
    "operatingleaseliabilitycurrent": 682000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:OtherLiabilitiesCurrent",
    "propertyplantandequipmentgross": 1941000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 677000,
    "depreciation": 356000,
    "licenseagreementdate": "November 23, 2016",
    "licenseagreementamendmentdate": "March 24, 2017",
    "milestonepayments": 500000,
    "licenseagreementterminationnoticeperiod": "P90D",
    "accruedexternalresearch": 2737000,
    "accruedprofessionalfeescurrent": 1487000,
    "accruedexternalclinicalstudycosts": 7996000,
    "employeerelatedliabilitiescurrent": 3183000,
    "cashpaymentsformeasurementofoperatingleases": 688000,
    "leaserightofuseasset": 9853000,
    "operatingleaseliability": 10217000,
    "operatingleaseweightedaverageremainingleaseterm1": "P7Y2M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.077,
    "operatingleasecost": 368000,
    "leasecost": 977000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1459000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2015000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2072000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1634000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1679000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 4855000,
    "lesseeoperatingleaseliabilitypaymentsdue": 13714000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 3497000,
    "stockholdersequityreversestocksplit": "In connection with the IPO, the Board of Directors and the stockholders of the Company approved a one-for-three reverse stock split of the Company’s common stock.",
    "preferredstocksharesauthorized": "null",
    "commonstockvotingrights": "Holders of common stock are entitled to one vote per share",
    "commonstockcapitalsharesreservedforfutureissuance": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardnumberofsharesavailableforgrant": 938738,
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten years",
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedstockoptions": 42049000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 2.69,
    "allocatedsharebasedcompensationexpense": 16449000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrateminimum": 0.742,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityratemaximum": 0.821,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrateminimum": 0.014,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestratemaximum": 0.026,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 14.94,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 326654,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 16.88,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 20.49,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 22.06,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 7.32,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 8.93,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageexerciseprice": 16.88,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y1M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingweightedaverageremainingcontractualterm1": "P7Y6M",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 72251000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 58797000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestoutstandingaggregateintrinsicvalue": 72251000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "deferredtaxassetsvaluationallowance": 86000000,
    "operatinglosscarryforwards": 10900000,
    "operatinglosscarryforwardsexpirationyear": 2024,
    "operatinglosscarryforwardssubjecttoexpiration": 92700000,
    "operatinglosscarryforwardsnotsubjecttoexpiration": 193400000,
    "deferredtaxassetstaxcreditcarryforwardsresearch": 10900000,
    "taxcreditcarryforwardexpirationyear": 2034,
    "incometaxreconciliationincometaxexpensebenefitatfederalstatutoryincometaxrate": -25714000,
    "incometaxreconciliationstateandlocalincometaxes": 2369000,
    "incometaxreconciliationchangeindeferredtaxassetsvaluationallowance": 29499000,
    "incometaxreconciliationnetoperatinglossandresearchanddevelopmentcreditcarryforwards": 1858000,
    "incometaxreconciliationnondeductibleexpensesharebasedcompensationcost": 461000,
    "incometaxreconciliationtaxcreditsresearch": 3529000,
    "incometaxreconciliationotherreconcilingitems": 206000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 2205000,
    "deferredtaxassetsoperatingleaseliabilities": 2348000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 4865000,
    "deferredtaxassetscharitablecontributioncarryforwards": 6000,
    "deferredtaxassetscapitalizedpatentsandlicenses": 2156000,
    "deferredtaxassetsoperatinglosscarryforwards": 65869000,
    "deferredtaxassetsgross": 88323000,
    "deferredtaxliabilitiesleasingarrangements": 2263000,
    "deferredtaxliabilitiespropertyplantandequipment": 60000,
    "deferredincometaxliabilities": 2323000,
    "valuationallowancesandreservesbalance": 86000000,
    "valuationallowancesandreserveschargedtocostandexpense": 31357000,
    "valuationallowancesandreservesdeductions": 1858000,
    "relatedpartytransactionamountsoftransaction": 6000
  }
]